glp 1 blue cross IBX members face GLP-1 drug costs after insurance change Results of two-year study show

doi:10.1016/j.cbi.2005.12.009 3

In a New York Times opinion column explaining why the FDA is taking action this week, Commissioner Marty Makary highlighted online pharmacies marketing drugs without presenting an adequate balance of risks, and in particular a Super Bowl ad from Hims & Hers parading the benefits of GLP-1 drugs without any mention of side effects. But the compounding letters scope is narrower than that messaging suggests

Efficacy: Patients undergoing bariatric surgery often achieve a loss of 25% to 35% of their total body weight, with long-term maintenance being more common than with medication or diet alone

Serious risks like allergic reactions or kidney stress can occur with unsupervised or high-dose treatments

But sometimes life gets in the way